Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2015-01-09)Premium Content

Astrazeneca Plc (AZN)

2015-01-29@12:49:50 ET
AstraZeneca (AZN) Showing Bearish Technicals With Resistance At $72.56 (FBM)

2015-01-29@12:44:00 ET
AstraZeneca, MD Anderson Enter Collaboration to Help Improve Patient Outcomes in Ovarian/ Gynecologic Cancers (BIZ)

2015-01-28@16:26:49 ET
AstraZeneca (AZN) Trading Near $72.75 Resistance Level (FBM)

2015-01-27@17:17:34 ET
Look for Shares of AstraZeneca to Potentially Pullback after Yesterday's 1.87% Rise (PSM)

2015-01-27@17:16:59 ET
AstraZeneca Set to Possibly Pullback After Yesterday's Rally of 1.87% (PSM)

2015-01-27@11:56:00 ET
Global Pediatric Drugs and Vaccines Market (PRN)

2015-01-27@11:31:17 ET
Dyslipidemia Therapeutic Pipeline Companies and Drugs Review H1 2015 Report at (PRW)

2015-01-27@08:31:47 ET
Pyelonephritis Therapeutic Pipeline Review H1 2015 Market Research Report at (PRW)

2015-01-25@11:30:11 ET
Constipation Therapeutic Pipeline Companies and Drugs Review H1 2015 Report at (PRW)

2015-01-23@16:31:02 ET
Atrial Fibrillation Therapeutic Pipeline Review H1 2015 Report at (PRW)

2015-01-23@15:26:03 ET
Potential AstraZeneca (AZN) Trade Has 3.40% Downside Protection (FBM)

2015-01-22@12:04:04 ET
Bearish Moving Average Cross by AstraZeneca (AZN) (F78)

2015-01-22@11:56:41 ET
AstraZeneca (AZN) Showing Neutral Technicals (FBM)

2015-01-21@10:40:34 ET
Potential AstraZeneca (AZN) Trade Could Hit 2.22% Return (FBM)

2015-01-21@08:39:21 ET
Possible Bearish Inside Day Candle Pattern Detected for AstraZeneca (NYSE:AZN) (F70)

2015-01-20@08:22:59 ET
AstraZeneca's acute coronary syndrome study meets primary efficacy endpoint (DTM)

2015-01-20@06:15:20 ET
Pharmaceutical-Bio Industry's First-Quarter 2015 Capital and Maintenance Project Starts Near $4 Billion Investment in North America, an Industrial Info News Alert (INW)

2015-01-15@13:50:51 ET
AstraZeneca (AZN) Showing Resistance Near $72.11 (FBM)

2015-01-14@08:18:02 ET
AstraZeneca (AZN) Showing Support Near $69.29 (FBM)

2015-01-14@07:00:25 ET
PEGASUS-TIMI 54 Study of BRILINTA(R) Meets Primary Endpoint in Both 60mg and 90mg Doses (BIZ)